Regrelor Disodium

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameRegrelor Disodium
Drug Alias Name瑞格瑞洛钠Regrelorumregrelor瑞格雷洛钠INS-50589 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsCoronary DiseaseCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsCoronary DiseaseCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksKEGG